Li, Xiang
Yu, Wei
Wollenweber, Tim
Lu, Xia
Wei, Yongxiang
Beitzke, Dietrich
Wadsak, Wolfgang
Kropf, Saskia
Wester, Hans J.
Haug, Alexander R.
Zhang, Xiaoli
Hacker, Marcus http://orcid.org/0000-0002-4222-4083
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 1 December 2018
Accepted: 27 March 2019
First Online: 19 April 2019
Compliance with ethical standards
:
: Hans-Jürgen Wester is shareholder of SCINTOMICS GmbH, Germany. SCINTOMICS owns the IP on Pentixafor.The other enlisted authors have no conflict of interest to declare.
: Our study reports two independent cohorts, which were analyzed independently, after receiving ethical permission from both ethical committees (Vienna and Peking).